Article Versions Notes

Spadea A, Tirella A, Rios de la Rosa JM, Lallana E, Mehibel M, Telfer B, Tirelli N, Lawrence MJ, Williams KJ, Stratford IJ, et al. Targeting Hypoxia-Inducible Factor-1α in Pancreatic Cancer: siRNA Delivery Using Hyaluronic Acid-Displaying Nanoparticles. Pharmaceutics. 2024; 16(10):1286. https://doi.org/10.3390/pharmaceutics16101286

Spadea, Alice, Annalisa Tirella, Julio Manuel Rios de la Rosa, Enrique Lallana, Manal Mehibel, Brian Telfer, Nicola Tirelli, Margaret Jayne Lawrence, Kaye J. Williams, Ian J. Stratford, and et al. 2024. "Targeting Hypoxia-Inducible Factor-1α in Pancreatic Cancer: siRNA Delivery Using Hyaluronic Acid-Displaying Nanoparticles" Pharmaceutics 16, no. 10: 1286. https://doi.org/10.3390/pharmaceutics16101286

Spadea, A., Tirella, A., Rios de la Rosa, J. M., Lallana, E., Mehibel, M., Telfer, B., Tirelli, N., Lawrence, M. J., Williams, K. J., Stratford, I. J., & Ashford, M. (2024). Targeting Hypoxia-Inducible Factor-1α in Pancreatic Cancer: siRNA Delivery Using Hyaluronic Acid-Displaying Nanoparticles. Pharmaceutics, 16(10), 1286. https://doi.org/10.3390/pharmaceutics16101286